The mpox epidemic is not over: Reducing disproportionate burden in Africa and persistent global risk require a sustained response.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41632719.
- Also identified by DOI 10.1371/journal.pmed.1004893 and PMC identifier 12867245.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
While global interest in mpox may be waning, outbreaks, illness, and death continue across Africa and the world. Ending transmission requires a sustained global response that moves beyond reactive measures.
Medical subject headings
- Epidemics